扶正消瘤颗粒对人表皮生长因子受体 2 阳性 乳腺癌细胞迁移的实验研究
CSTR:
作者:
作者单位:

(深圳市第二人民医院 深圳大学第一附属医院,广东 深圳 518035)

作者简介:

田欢,女,副主任医师,主要研究方向是中西医结合肿瘤临床和基础研究。

通讯作者:

中图分类号:

R 737.9

基金项目:

深圳市科技创新委员会科技研发资金资助课题(JCYJ20140414170821153)


Experimental Study of FuzhengXiaoliu Granule on Cell Migration of Her–2 Positive Breast Cancer SKBR–3 Cell Line
Author:
Affiliation:

(Shenzhen Second People’s Hospital, the First Affi liated Hospital of Shenzhen University, Guangdong Shenzhen 518035)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕目的:观察扶正消瘤颗粒对人表皮生长因子受体 2(Her–2)阳性乳腺癌细胞 SKBR–3 迁移的影响及其作用机理。 方法:SKBR–3 细胞以 2×106·2 mL-1 的密度接种到 6 孔培养板中,共 5 组。72 h 后损伤细胞,并加入 1 倍、2 倍、3 倍 剂量的扶正消瘤颗粒含药血清,以曲妥珠单抗为阳性对照,空白血清为空白对照。加药后 24 h、48 h 和 72 h 细胞划痕实验 观察扶正消瘤颗粒对 SKBR–3 细胞迁移的影响;SKBR–3 细胞培养 48 h,加入上述药物,24 h 后 Western blot 检测 Her–2 蛋白的表达。结果:扶正消瘤颗粒和曲妥珠单抗抑制 SKBR–3 细胞迁移的作用明显,24 h、48 h 和 72 h 三个时间点,与空 白对照组比较,差异具有统计学意义(P < 0.05 ~ 0.01),Western blot 结果显示扶正消瘤颗粒 1 倍剂量组和 2 倍剂量组对 SKBR–3 细胞 Her–2 蛋白表达无明显作用,与空白对照组比较,差异均无统计学意义(P > 0.05);扶正消瘤颗粒 3 倍剂量 组抑制 Her–2 蛋白的表达,与空白对照组比较,差异具有统计学意义(P < 0.05)。曲妥珠单抗明显抑制 Her–2 蛋白表达, 与扶正消瘤颗粒 1 倍剂量组和 2 倍剂量组及空白对照组比较,差异均具有统计学意义(P < 0.01)。结论:扶正消瘤颗粒 能明显抑制乳腺癌 SKBR–3 细胞迁移,3 倍剂量的扶正消瘤颗粒和曲妥珠单抗对 SKBR–3 细胞 Her–2 蛋白表达具有抑制作用。

    Abstract:

    〔Abstract〕 Objective To observe the effect and mechanism of Fuzheng Xiaoliu Granule on the migration of Her-2 positive breast cancer SKBR–3 cell line. Methods 5 groups of SKBR-3 cells were plated at the density of 2×106·2 mL-1 into 6 well culture plates and injured at 72h, 1 times dosage, 2 times dosage and 3 times dosage of Fuzhengxiaoliu granule containing serum were added in, Trastuzumab and blank serum were used as positive and blank control. After dosing 24h、48h、72h, Cell Scratch test were used to detect the cell migration of SKBR-3 cells; SKBR–3 cells were cultured for 48 hours, and the expression of Her–2 protein was detected by Western blot after 24 hours of treatment. Results The inhibitory effects of Fuzheng Xiaoliu Granule and Trastuzumab on the migration of SKBR-3 cells were signifi cant, Compared with the Blank control group, the difference were statistically signifi cant in 24h, 48h and 72h (P < 0.05~0.01); Western blot showed that 1 times dosage and 2 times dosage of Fuzheng Xiaoliu granule had no effect on the expression of Her-2 protein in SKBR-3 cells,compared with blank control group, there were no signifi cant difference (P > 0.05); The expression of Her-2 protein in the 3 times dose group of Fuzheng Xiaoliu Granule was signifi cantly lower than that in the blank control group (P < 0.05); Trastuzumab signifi cantly inhibited Her-2 protein expression, Compared with 1 times dosage, 2 times dosage of Fuzheng Xiaoliu granule and the Blank control group, the difference were statistically signifi cant(P < 0.01). Conclusion FuZheng XiaoLiu granule obviously inhibited the migration of breast cancer SKBR-3 cells; 3 times dose of Fuzheng Xiaoliu Granule and Trastuzumab inhibited the expression of Her-2 protein in SKBR-3 cells.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-11-11
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-12-01
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭